692 related articles for article (PubMed ID: 6606612)
1. In-vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. I. Effect of anti-Thy-1 antibody on the tissue distribution of lymphocytes.
Le Gros GS; Prestidge RL; Watson JD
Immunology; 1983 Dec; 50(4):537-46. PubMed ID: 6606612
[TBL] [Abstract][Full Text] [Related]
2. Immunohistology of lymphoid and non-lymphoid cells in the thymus in relation to T lymphocyte differentiation.
Van Ewijk W
Am J Anat; 1984 Jul; 170(3):311-30. PubMed ID: 6332520
[TBL] [Abstract][Full Text] [Related]
3. Treatment of murine lupus with monoclonal antibody to L3T4. II. Effects on immunohistopathology of thymus, spleen, and lymph node.
Ermak TH; Steger HJ; Wofsy D
Lab Invest; 1989 Oct; 61(4):447-56. PubMed ID: 2529396
[TBL] [Abstract][Full Text] [Related]
4. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. II. Separation of natural killer cells and cytotoxic T cells.
Le Gros GS; Herbert AG; Watson JD
Immunology; 1984 Jan; 51(1):103-13. PubMed ID: 6606615
[TBL] [Abstract][Full Text] [Related]
5. A new autoreactive monoclonal antibody specific for the Thy-1 antigen.
Rabinowitz R; Hadar R; Laskov R; Schlesinger M
Thymus; 1986; 8(5):279-94. PubMed ID: 2879369
[TBL] [Abstract][Full Text] [Related]
6. Detection of Thy-1, T-200, Lyt-1 and Lyt-2-bearing cells in the developing lymphoid organs of the mouse embryo in vivo and in vitro.
Van Ewijk W; Jenkinson EJ; Owen JJ
Eur J Immunol; 1982 Apr; 12(4):262-71. PubMed ID: 6124425
[TBL] [Abstract][Full Text] [Related]
7. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
[TBL] [Abstract][Full Text] [Related]
8. In vivo effects in mice of an anti-T cell immunotoxin.
Marcucci F; Lappi DA; Ghislieri M; Martineau D; Formosa A; Siena S; Bregni M; Soria M; Gianni AM
J Immunol; 1989 Apr; 142(8):2955-60. PubMed ID: 2564860
[TBL] [Abstract][Full Text] [Related]
9. Two distinct antigenic markers for rat thymus and T cells defined by monoclonal antibodies.
Ishii Y; Matsuura A; Yuasa H; Narita H; Takami T; Kikuchi K
Immunology; 1983 Apr; 48(4):743-54. PubMed ID: 6339377
[TBL] [Abstract][Full Text] [Related]
10. A new model for investigations of T-cell functions in mice: differential immunosuppressive effects of two monoclonal anti-Thy-1.2 antibodies.
Opitz HG; Opitz U; Hewlett G; Schlumberger HD
Immunobiology; 1982 Feb; 160(5):438-53. PubMed ID: 7040212
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to murine cell surface antigens. I. Lyt-1.1.
Hogarth PM; Potter TA; Cornell FN; McLachlan R; McKenzie IF
J Immunol; 1980 Oct; 125(4):1618-24. PubMed ID: 6997382
[TBL] [Abstract][Full Text] [Related]
12. Importance of Lyt 2+ T-cells in the curative effectiveness of a low dose of melphalan for mice bearing a large MOPC-315 tumor.
Mokyr MB; Barker E; Weiskirch LM; Takesue BY; Pyle JM
Cancer Res; 1989 Aug; 49(16):4597-606. PubMed ID: 2568174
[TBL] [Abstract][Full Text] [Related]
13. Functional and binding activity of monoclonal anti-Thy-1 antibodies: evidence for different expression of the two alleles.
Abehsira O; Edwards A; Simpson E
Eur J Immunol; 1981 Apr; 11(4):275-81. PubMed ID: 6788568
[TBL] [Abstract][Full Text] [Related]
14. Population dynamics of T lymphocytes. Renewal rate and expansion in the peripheral lymphoid organs.
Rocha B; Freitas AA; Coutinho AA
J Immunol; 1983 Nov; 131(5):2158-64. PubMed ID: 6605376
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen.
Lazarovits AI; Moscicki RA; Kurnick JT; Camerini D; Bhan AK; Baird LG; Erikson M; Colvin RB
J Immunol; 1984 Oct; 133(4):1857-62. PubMed ID: 6088627
[TBL] [Abstract][Full Text] [Related]
16. Antilymphocytic antibodies and bone marrow transplantation. XI. Evidence that reduced Thy-1 expression in Thy-1.1 mice prevents suppression of graft-versus-host disease with anti-Thy-1 monoclonal antibodies.
Mysliwietz J; Thierfelder S; Hoffmann-Fezer G; Kummer U
Transplantation; 1990 Apr; 49(4):749-55. PubMed ID: 1970200
[TBL] [Abstract][Full Text] [Related]
17. Implication of the Thy-1 antigen on mouse thymus cells in the recognition of 'self' structures.
Levy J; Rabinowitz R; Schlesinger M
Thymus; 1985; 7(2):85-93. PubMed ID: 2409645
[TBL] [Abstract][Full Text] [Related]
18. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
Buessow SC; Paul RD; Lopez DM
J Natl Cancer Inst; 1984 Jul; 73(1):249-55. PubMed ID: 6610791
[TBL] [Abstract][Full Text] [Related]
19. Developmental sequence of T200 antigen modifications in murine T cells.
Lefrancois L; Goodman T
J Immunol; 1987 Dec; 139(11):3718-24. PubMed ID: 2960741
[TBL] [Abstract][Full Text] [Related]
20. Human thy-1: unusual localization and possible functional significance in lymphoid tissues.
McKenzie JL; Fabre JW
J Immunol; 1981 Mar; 126(3):843-50. PubMed ID: 7462633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
